Suppr超能文献

人5-HT7受体(h5-HT7b)截短剪接变体的克隆、表达及药理学研究

Cloning, expression and pharmacology of a truncated splice variant of the human 5-HT7 receptor (h5-HT7b).

作者信息

Jasper J R, Kosaka A, To Z P, Chang D J, Eglen R M

机构信息

Center for Biological Research, Roche Bioscience, Palo Alto, CA 94304, USA.

出版信息

Br J Pharmacol. 1997 Sep;122(1):126-32. doi: 10.1038/sj.bjp.0701336.

Abstract
  1. The rat 5-hydroxytryptamine (5-HT)7 receptor displays two splice variations, a long form, and a truncated splice isoform, arising from the introduction of a stop codon near the carboxy-terminus. The human-5HT7 receptor gene contains at least two introns and encodes a 445 amino acid 5-HT receptor. 2. A truncated splice variation in the human 5-HT7 receptor was isolated from a human placental cDNA library. In accordance with current NC-IUPHAR nomenclature guidelines, it is suggested that this receptor be donated as the h5-HT7b receptor and the long form of the receptor as h5-HT7a. 3. The h5-HT7b receptor was stably expressed in HEK 293 cells and ligand affinities were determined by displacement of [3H]-5-carboxyamidotryptamine (5-CT; Kd = 0.28 +/- 0.6 nM, Bmax = 7.3 +/- 17 pmol mg-1 protein). The rank order of affinities (pKi) for a series of ligands was: 5-carboxamidotryptamine (5-CT, 9.65) > 5-hydroxytryptamine (5-HT, 9.41) > methiothepin (8.87) > mesulergine (7.87) > 8-hydroxy-2 (di-n-propylamino)tetralin (8-OH-DPAT, 6.85) > ketanserin (6.44). 4. The h5-HT7b receptor coupled positively to adenylyl cyclase in HEK 293 cells. This response was elicited by a number of agonists with the following order of potency (pEC50): 5-CT (8.7 +/- 0.11) > 5-MeOT (5-methoxytryptamine; 8.1 +/- 0.20) > 5-HT (7.5 +/- 0.13) tryptamine (5.6 +/- 0.36) > 8-OH-DPAT (5.3 +/- 0.28) > 5-methoxytryptamine (5.0 +/- 0.06). This rank order was comparable to that observed in the radioligand binding studies. 5. In a similar fashion to that described for the 5-HT7a receptor, PCR studies suggested that the 5-HT7b receptor mRNA is found in great abundance throughout the brain, in the small intestine and aorta. 6. It is concluded that the h5-HT7 receptor, like the rat receptor, exists as splice variants exhibiting similar pharmacology, signal transduction and distribution. It is thus likely that there exists a complex physiological role for alternate splicing products of the 5-HT7 receptor gene.
摘要
  1. 大鼠5-羟色胺(5-HT)7受体存在两种剪接变体,一种是长形式,另一种是截短的剪接异构体,后者是由于在羧基末端附近引入了一个终止密码子而产生的。人5-HT7受体基因至少包含两个内含子,编码一个由445个氨基酸组成的5-HT受体。2. 从人胎盘cDNA文库中分离出了人5-HT7受体的一种截短剪接变体。根据当前的NC-IUPHAR命名指南,建议将该受体命名为h5-HT7b受体,而将该受体的长形式命名为h5-HT7a。3. h5-HT7b受体在HEK 293细胞中稳定表达,并通过[3H]-5-羧基酰胺色胺(5-CT;Kd = 0.28 +/- 0.6 nM,Bmax = 7.3 +/- 17 pmol mg-1蛋白)的置换来确定配体亲和力。一系列配体的亲和力(pKi)排序为:5-羧基酰胺色胺(5-CT,9.65)> 5-羟色胺(5-HT,9.41)> 甲硫哒嗪(8.87)> 美舒麦角林(7.87)> 8-羟基-2(二正丙基氨基)四氢萘(8-OH-DPAT,6.85)> 酮色林(6.44)。4. h5-HT7b受体在HEK 293细胞中与腺苷酸环化酶呈正偶联。这种反应由多种激动剂引发,其效力顺序(pEC50)如下:5-CT(8.7 +/- 0.11)> 5-甲氧基色胺(5-MeOT;8.1 +/- 0.20)> 5-HT(7.5 +/- 0.13)> 色胺(5.6 +/- 0.36)> 8-OH-DPAT(5.3 +/- 0.28)> 5-甲氧基色胺(5.0 +/- 0.06)。该排序与放射性配体结合研究中观察到的结果相当。5. 与5-HT7a受体的描述方式类似,PCR研究表明5-HT7b受体mRNA在整个大脑、小肠和主动脉中大量存在。6. 得出的结论是,人5-HT7受体与大鼠受体一样,以剪接变体的形式存在,表现出相似的药理学、信号转导和分布。因此,5-HT7受体基因的可变剪接产物可能存在复杂的生理作用。

相似文献

引用本文的文献

1
"Selective" serotonin 5-HT receptor antagonists.“选择性”血清素 5-HT 受体拮抗剂。
Biochem Pharmacol. 2022 Jun;200:115028. doi: 10.1016/j.bcp.2022.115028. Epub 2022 Apr 4.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验